IBDEI14G ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20099,0)
 ;;=302.72^^131^1284^35
 ;;^UTILITY(U,$J,358.3,20099,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20099,1,4,0)
 ;;=4^302.72
 ;;^UTILITY(U,$J,358.3,20099,1,5,0)
 ;;=5^Impotence, Psychosocial
 ;;^UTILITY(U,$J,358.3,20099,2)
 ;;=^100632
 ;;^UTILITY(U,$J,358.3,20100,0)
 ;;=788.30^^131^1284^61
 ;;^UTILITY(U,$J,358.3,20100,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20100,1,4,0)
 ;;=4^788.30
 ;;^UTILITY(U,$J,358.3,20100,1,5,0)
 ;;=5^Urinary Incontinence,Unspec
 ;;^UTILITY(U,$J,358.3,20100,2)
 ;;=^124400
 ;;^UTILITY(U,$J,358.3,20101,0)
 ;;=V13.01^^131^1284^25
 ;;^UTILITY(U,$J,358.3,20101,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20101,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,20101,1,5,0)
 ;;=5^Hx Of Kidney Stone
 ;;^UTILITY(U,$J,358.3,20101,2)
 ;;=^303403
 ;;^UTILITY(U,$J,358.3,20102,0)
 ;;=302.71^^131^1284^36
 ;;^UTILITY(U,$J,358.3,20102,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20102,1,4,0)
 ;;=4^302.71
 ;;^UTILITY(U,$J,358.3,20102,1,5,0)
 ;;=5^Loss Of Libido
 ;;^UTILITY(U,$J,358.3,20102,2)
 ;;=^1
 ;;^UTILITY(U,$J,358.3,20103,0)
 ;;=596.54^^131^1284^38
 ;;^UTILITY(U,$J,358.3,20103,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20103,1,4,0)
 ;;=4^596.54
 ;;^UTILITY(U,$J,358.3,20103,1,5,0)
 ;;=5^Neurogenic Bladder 
 ;;^UTILITY(U,$J,358.3,20103,2)
 ;;=^304798
 ;;^UTILITY(U,$J,358.3,20104,0)
 ;;=788.43^^131^1284^39
 ;;^UTILITY(U,$J,358.3,20104,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20104,1,4,0)
 ;;=4^788.43
 ;;^UTILITY(U,$J,358.3,20104,1,5,0)
 ;;=5^Nocturia
 ;;^UTILITY(U,$J,358.3,20104,2)
 ;;=^84740
 ;;^UTILITY(U,$J,358.3,20105,0)
 ;;=605.^^131^1284^42
 ;;^UTILITY(U,$J,358.3,20105,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20105,1,4,0)
 ;;=4^605.
 ;;^UTILITY(U,$J,358.3,20105,1,5,0)
 ;;=5^Phimosis
 ;;^UTILITY(U,$J,358.3,20105,2)
 ;;=^104159
 ;;^UTILITY(U,$J,358.3,20106,0)
 ;;=601.0^^131^1284^44
 ;;^UTILITY(U,$J,358.3,20106,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20106,1,4,0)
 ;;=4^601.0
 ;;^UTILITY(U,$J,358.3,20106,1,5,0)
 ;;=5^Prostatitis, Acute
 ;;^UTILITY(U,$J,358.3,20106,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,20107,0)
 ;;=590.10^^131^1284^46
 ;;^UTILITY(U,$J,358.3,20107,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20107,1,4,0)
 ;;=4^590.10
 ;;^UTILITY(U,$J,358.3,20107,1,5,0)
 ;;=5^Pyelonephritis, Acute
 ;;^UTILITY(U,$J,358.3,20107,2)
 ;;=^270369
 ;;^UTILITY(U,$J,358.3,20108,0)
 ;;=590.00^^131^1284^47
 ;;^UTILITY(U,$J,358.3,20108,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20108,1,4,0)
 ;;=4^590.00
 ;;^UTILITY(U,$J,358.3,20108,1,5,0)
 ;;=5^Pyelonephritis, Chronic
 ;;^UTILITY(U,$J,358.3,20108,2)
 ;;=^270367
 ;;^UTILITY(U,$J,358.3,20109,0)
 ;;=788.7^^131^1284^54
 ;;^UTILITY(U,$J,358.3,20109,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20109,1,4,0)
 ;;=4^788.7
 ;;^UTILITY(U,$J,358.3,20109,1,5,0)
 ;;=5^Urethral Discharge
 ;;^UTILITY(U,$J,358.3,20109,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,20110,0)
 ;;=131.02^^131^1284^57
 ;;^UTILITY(U,$J,358.3,20110,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20110,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,20110,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,20110,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,20111,0)
 ;;=597.80^^131^1284^55
 ;;^UTILITY(U,$J,358.3,20111,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20111,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,20111,1,5,0)
 ;;=5^Urethritis NOS
 ;;^UTILITY(U,$J,358.3,20111,2)
 ;;=Urethritis, NOS^124214
 ;;^UTILITY(U,$J,358.3,20112,0)
 ;;=788.41^^131^1284^58
 ;;^UTILITY(U,$J,358.3,20112,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20112,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,20112,1,5,0)
 ;;=5^Urinary Frequency
